[A case report of postoperative recurrent hepatocellular carcinoma effectively treated with HCFU administration combined with TAE].
A 62-year-old man was found to have recurrent hepatocellular carcinoma (HCC) 2 cm in diameter in the left lobe in June 1990. After right lobectomy of the liver which contained the tumors of S6 2 cm and S8 3 cm in diameter 7 months before, the patient was treated with hepatic arterial embolization (TAE) combined with infusion of anti-cancer drug (ADM, CDDP) four times since June 1990. HCFU 300 mg per day was administered orally since June 1990. Since the 3rd TAE in December, 1990, the tumor stain in the left lobe disappeared for 10 months till October, 1991. No remarkable side effect of HCFU was noticed during this period. HCFU administration combined with TAE effectively prevented post-surgical recurrence of HCC in this case.
Imai
Y
Y
Division of Gastroenterology, Mitsui Memorial Hospital, Japan.
Ito
J
J
Tanzawa
Y
Y
Toda
N
N
Okamoto
M
M
Kobayashi
K
K
Taniguchi
M
M
Uta
Y
Y
Tagawa
K
K
Unuma
T
T
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006498:Hepatectomy; D006499:Hepatic Artery; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011184:Postoperative Period
D000970:Antineoplastic Agents; C017367:carmofur; D005472:Fluorouracil